CN102018828A - Traditional Chinese medicine for treating benign prostatic hyperplasia - Google Patents

Traditional Chinese medicine for treating benign prostatic hyperplasia Download PDF

Info

Publication number
CN102018828A
CN102018828A CN2010102321494A CN201010232149A CN102018828A CN 102018828 A CN102018828 A CN 102018828A CN 2010102321494 A CN2010102321494 A CN 2010102321494A CN 201010232149 A CN201010232149 A CN 201010232149A CN 102018828 A CN102018828 A CN 102018828A
Authority
CN
China
Prior art keywords
chinese medicine
traditional chinese
prostatic hyperplasia
effect
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010102321494A
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2010102321494A priority Critical patent/CN102018828A/en
Publication of CN102018828A publication Critical patent/CN102018828A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a traditional Chinese medicine for treating benign prostatic hyperplasia, belonging to the field of the traditional Chinese medicine for treating urinary system diseases. The traditional Chinese medicine has the purposes of good effect and fast desired effect. The traditional Chinese medicine is prepared from the following raw materials: dianthus superbus, pseudo-ginseng, angelica, lucid ganoderma, medlar and the like, and has the effects of replenishing qi and nourishing blood, and activating blood and dissolving stasis and promoting urination and treating stranguria, and has the advantages of obvious effect and exact drug effect and fast desired effect.

Description

A kind of Chinese medicine for the treatment of prostatic hyperplasia
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of urinary system.
Background technology
The present Chinese medicine aspect that is used for the treatment of male prostatic hyperplasia, the deficiency that has two aspects: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of prostatic hyperplasia patients are because of can not get the treatment of active drug for a long time, frequent frequent micturition, urgent micturition, dysurea, unable, the urine retention of urine, urinary incontinence, protracted course of disease, symptoms such as very misery, and Chang Bingfa urine retention, hematuria, perineal position pain.Patient and family members thereof are very dissatisfied.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of prostatic hyperplasia, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, and the slower problem that takes effect is effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of prostatic hyperplasia adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Dianthi 5---50 parts of 40 portions of Radix Notoginseng 3---20 parts of Radix Angelicae Sinensis 6---
50 parts of Ganodermas 2---12 portions of Fructus Lyciis 6---
The Chinese medicine of this treatment prostatic hyperplasia is made by following method:
(1) by above-mentioned weight ratio, Herba Dianthi, Radix Angelicae Sinensis, Fructus Lycii are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with the extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Fructus Lycii the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; The Herba Dianthi inducing diuresis for treating stranguria syndrome is usually used in treating urinary obstruction, odynuria because of it has remarkable diuresis.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of inducing diuresis for treating stranguria syndrome, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Dianthi 60 gram Radix Notoginseng 30 gram Radix Angelicae Sinensis 60 grams
Ganoderma 20 gram Fructus Lyciis 60 grams
Weight in accordance with regulations, with conventional water extraction process Herba Dianthi, Radix Angelicae Sinensis, Fructus Lycii are extracted, make extractum fine powder 54 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with the extractum fine powder, make fine particle, adorn capsule No. 0, make 371 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Herba Dianthi 200 gram Radix Notoginseng 100 gram Radix Angelicae Sinensis 250 grams
Ganoderma 60 gram Fructus Lyciis 250 grams
By above-mentioned same method, make 1375 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Herba Dianthi 400 gram Radix Notoginseng 200 gram Radix Angelicae Sinensis 500 grams
Ganoderma 120 gram Fructus Lyciis 500 grams
By above-mentioned same method, make 2642 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
7 parts of 3 parts of Radix Angelicae Sinensis of 6 portions of Radix Notoginseng of Herba Dianthi
7 parts of 2 portions of Fructus Lyciis of Ganoderma
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
22 parts of 9 parts of Radix Angelicae Sinensis of 18 portions of Radix Notoginseng of Herba Dianthi
22 parts of 6 portions of Fructus Lyciis of Ganoderma
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is example with the prostatic hyperplasia, through 7 routine clinical observations.Selecting the tcm diagnosis prostatic hyperplasia is standard: male's limb is soft weak, physical weakness, and it is not smooth to urinate---and frequent micturition, urgent micturition, dysurea, urine are unable, urine retention, urine are hesitated, urine retention.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, be the male all, there is not other serious disease, the age is 49 years old-81 years old, 71.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are obviously alleviated; Urine retention, urine are hesitated, urine retention obviously alleviates.
2, effective: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are alleviated to some extent; Urine is hesitated, urine retention alleviates to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 3 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 4 people, effective 2 people, invalid 1 people, total effective rate 85.7%.

Claims (1)

1. Chinese medicine for the treatment of prostatic hyperplasia is characterized in that making by comprising the following traditional Chinese medicines prescription: Herba Dianthi 5---and 40 parts, Radix Notoginseng 3---20 parts, Radix Angelicae Sinensis 6---50 parts, Ganoderma 2---12 parts, Fructus Lycii 6---50 parts.
CN2010102321494A 2010-07-15 2010-07-15 Traditional Chinese medicine for treating benign prostatic hyperplasia Pending CN102018828A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102321494A CN102018828A (en) 2010-07-15 2010-07-15 Traditional Chinese medicine for treating benign prostatic hyperplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102321494A CN102018828A (en) 2010-07-15 2010-07-15 Traditional Chinese medicine for treating benign prostatic hyperplasia

Publications (1)

Publication Number Publication Date
CN102018828A true CN102018828A (en) 2011-04-20

Family

ID=43860877

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102321494A Pending CN102018828A (en) 2010-07-15 2010-07-15 Traditional Chinese medicine for treating benign prostatic hyperplasia

Country Status (1)

Country Link
CN (1) CN102018828A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101530515A (en) * 2008-03-13 2009-09-16 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetes mellitus complicated by intumescent prostate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101530515A (en) * 2008-03-13 2009-09-16 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetes mellitus complicated by intumescent prostate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王双龙: "中医药治疗前列腺炎进展", 《中医药信息》, no. 1, 31 January 1994 (1994-01-31), pages 15 - 17 *

Similar Documents

Publication Publication Date Title
CN101843699B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN102114172A (en) Traditional Chinese medicine for treating hyperplasia of prostate
CN102068594A (en) Chinese medicament for treating chronic prostatitis
CN102091225A (en) Traditional Chinese medicine for treating chronic prostatitis
CN102172374A (en) Traditional Chinese medicine for treating hyperplasia of prostate
CN101843804A (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101953937A (en) Chinese medicament for treating chronic prostatitis
CN101972349A (en) Traditional Chinese medicine for treating benign prostatic hyperplasia
CN102068529A (en) Traditional Chinese medicine for treatment of prostatic hyperplasia
CN101843733B (en) Chinese medicament for treating ichthyosis
CN101843778B (en) Chinese medicament for treating ichthyosis
CN102018760A (en) Traditional Chinese medicine for treating benign prostatic hyperplasia
CN101961416A (en) Traditional Chinese medicine for treating chronic prostatitis
CN101972426A (en) Traditional Chinese medicine for treating chronic prostatitis
CN102139009A (en) Traditional Chinese medicine for treating chronic prostatitis
CN102389477A (en) Traditional Chinese medicine for treating benign prostatic hyperplasia
CN102114122A (en) Traditional Chinese medicine for treating chronic prostatitis
CN101850020B (en) Chinese medicament for treating chronic kidney failure
CN101843693A (en) Chinese medicament for treating diabetic nephropathy
CN101843775A (en) Chinese medicament for treating diabetic nephropathy
CN101843803A (en) Chinese medicament for treating diabetic nephropathy
CN102018828A (en) Traditional Chinese medicine for treating benign prostatic hyperplasia
CN102018856A (en) Traditional Chinese medicine for treating chronic prostatitis
CN101843816B (en) Chinese medicament for treating chronic nephritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110420